As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive ...

A new device that researchers developed aims to bring a new artificial pancreas that is more suitable as an implant for the body, focusing on diabetic patients that need the organ. It claims to avoid ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable ...

– New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of the TLR9 agonist, SD-101, in metastatic uveal melanoma, ...

This autoimmune disease impacts millions of people worldwide, with some underserved communities bearing the brunt ...

In December 1921, 14-year-old Leonard Thompson was near death. The boy had diabetes and weighed just 65 pounds. After a month in Toronto General Hospital, he wasn’t improving, so his physicians turned ...

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...